Is lamictal (lamotrigine) associated with gynecomastia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lamotrigine (Lamictal) and Gynecomastia

Lamotrigine is not significantly associated with gynecomastia, unlike other medications such as spironolactone which has a well-documented risk of this side effect. 1

Medications Known to Cause Gynecomastia

Gynecomastia is a benign condition characterized by breast tissue enlargement in males. Several medications have been definitively linked to this condition:

  • Spironolactone - This aldosterone antagonist is strongly associated with gynecomastia, with a significantly higher risk compared to eplerenone (another medication in the same class) 1
  • Other medications with good evidence of association: 2
    • Cimetidine
    • Ketoconazole
    • Human growth hormone (hGH)
    • Estrogens
    • Human chorionic gonadotropin (hCG)
    • Anti-androgens
    • GnRH analogs
    • 5-α reductase inhibitors

Medications with Probable Association to Gynecomastia

  • Risperidone
  • Calcium channel blockers (verapamil, nifedipine)
  • Omeprazole
  • Alkylating agents
  • HIV medications (particularly efavirenz)
  • Anabolic steroids
  • Alcohol
  • Opioids 2

Pathophysiology of Drug-Induced Gynecomastia

Gynecomastia typically develops due to:

  • An imbalance in the estrogen/androgen ratio
  • Increased prolactin levels 3
  • Interference with hormone production or action 2

Lamotrigine and Gynecomastia

Lamotrigine (Lamictal) is not listed among medications with established or probable association with gynecomastia in any of the comprehensive reviews on drug-induced gynecomastia 3, 2, 4. Unlike medications such as spironolactone, which has a documented 9.1% rate of gynecomastia compared to 1.3% in placebo groups, lamotrigine does not appear in the literature as a significant cause 1.

Clinical Implications

When evaluating a patient with gynecomastia who is taking lamotrigine:

  • Consider other medications in the patient's regimen that have stronger associations with gynecomastia 2
  • Look for combinations of medications that might have synergistic effects, as seen in cases with certain antidepressants 5
  • Evaluate for other common causes of gynecomastia (hormonal disorders, liver disease, obesity, etc.) 3

Common Pitfalls in Evaluating Drug-Induced Gynecomastia

  • Failure to consider medication combinations: Some cases of gynecomastia occur only when certain medications are used together 5
  • Overlooking dose-dependent effects: Some medications cause gynecomastia in a dose-dependent manner 6
  • Attributing gynecomastia to the wrong medication: When multiple medications are being taken, it's important to identify which one is most likely responsible 2

Conclusion

Based on current evidence, lamotrigine (Lamictal) is not significantly associated with gynecomastia. If a patient taking lamotrigine develops gynecomastia, other medications or medical conditions should be considered as more likely causes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug-induced gynecomastia: an evidence-based review.

Expert opinion on drug safety, 2012

Research

[Drug-induced gynecomastia].

Annales de medecine interne, 2000

Research

Antidepressant-selective gynecomastia.

The Annals of pharmacotherapy, 2013

Research

Gynecomastia: A Rare Adverse Effect of Methylphenidate in an Adolescent Boy.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.